<p>As a sensitivity analysis, each comparison was evaluated in the subpopulations having the following requirements on prior exposure to antihyperglycemic agents (AHAs):</p>
<ul>
<li>No restrictions on prior exposure to AHA.</li>
<li>Having at least 1 prior non-metformin AHA exposure in 365 days prior to first exposure to the AHAs in the comparison</li>
<li>Having no prior non-metformin AHA exposure in 365 days prior to first exposure to the AHAs in the comparison</li>
<li>Having no prior exposure to the comparator drug prior to first exposure to the AHAs in the comparison</li>
</ul>